Introduction
Osteoarthritis (OA) is a chronic and progressive joint disorder characterized by structural damage to one or more joints. Symptoms vary from mild to severe joint pain and stiffness, often leading to loss of joint function and permanent disability. Genetic as well as acquired factors, including trauma and life-style associated features such as obesity contribute to the disease. OA is considered a disease of the whole joint: in addition to the articular cartilage, the subchondral bone and synovium also play important roles in onset and progression of OA. In early stages cell proliferation and enhanced matrix remodeling occur simultaneously in both cartilage and bone. When the balance between anabolic and catabolic processes in the joint is lost, the remodeling response results in articular cartilage degradation, osteophyte formation and subchondral bone sclerosis. The latter is associated with reduced mineralization secondary to increased tissue turnover and leading to impaired bone quality 1 . Polymorphisms in Frizzled-related protein (FRZB/SFRP3) have been associated with OA 2 , although this has been challenged more recently in genetic studies of very large cohorts 3 . Nevertheless, mice with loss of Frzb show increased severity of OA in different acute models 4 . FRZB is a member of the secreted frizzled-related protein (SFRP) family, which includes five members (SFRP1-5). .
Subchondral bone plate histomorphometry
Histomorphometry was performed on Safranin-O-stained sections using an Olympus DP73 microscope and digital image analysis using Osteomeasure software. First, a box with a fixed width (800 mM) and variable height with the upper limit at the transition of calcified cartilage to subchondral bone and the lower limit at the transition subchondral bone to growth plate was created from the digital image (referred to as subchondral bone area, area defined by blue line in [ Fig. 2(A) ]. Next, a new box with the upper limit matched to the first box and the lower limit at the transition of the subchondral bone plate to trabecular bone was generated (referred to as subchondral bone plate area, area defined by white line in [ Fig. 2(A) ]. The lined surface areas were calculated using the Osteomeasure software. To correct for variances due to section artifacts, we do not show the subchondral bone plate surface area per se, but express the subchondral bone plate thickness as a ratio of the subchondral bone plate area to the subchondral bone area.
Immunohistochemistry
Procedures and materials used for immunohistochemistry are presented in Supplementary Materials.
Statistics
All analyses were performed with GraphPad Prism. We hypothesized that the dependent variables (OA severity and subchondral bone plate thickness) could be determined by two independent variables (genotype and surgery) and therefore tested the effect of genotype, surgical intervention and their interaction using 2-way analysis of variance (ANOVA). The assumptions underlying the ANOVA were assessed: the dependent variables were measured at a ratio level and the independent variables were categorical, independent and based on independent observations. For subchondral bone plate analysis, data were normally distributed in the SFRP1 experiment based on visual analysis and the D'Agostino e Pearson omnibus normality test. In the FRZB experiment one outlier was identified by the Grubbs method affecting the normal distribution. Removal of the outlier resulted in a normal distribution assessed as above. Four-group analyses in both setups suggested homogeneity of variance for both original and cleaned datasets based on the BrowneForsythe test. For OA severity analysis, data were not normally distributed and there was no homogeneity of variance. We therefore performed a log transformation of the scores resulting in positive assessment of the normal distribution for the different datasets and homogeneity of variance assessed as above. ROUT and Grubbs method did identify outliers in both the FRZB and SFRP1 experiments. 2-way ANOVA was performed on original as well as cleaned datasets. Only the analysis of the original data is reported as removal of outliners emphasized detected differences with smaller 95% confidence intervals (CIs) of differences between means. If a significant interaction was detected, post-hoc Sidak test taking into account multiple comparisons was applied. Data are presented as mean þ 95% CI and Pvalues < 0.05 were considered significant. In the post-hoc tests, adjusted P-values < 0.05 correspond with 95% CI for differences between means that do not contain the zero value.
Results
To study the role of SFRPs in a slowly progressing model of OA, the DMM model was induced in Frzb À/À , Sfrp1 À/À and wild-type mice. 8-weeks after induction, OA severity scores were significantly higher in the tibia of Frzb À/À mice as compared to littermates (2-way ANOVA) P ¼ 0.0105 for interaction between genotype and intervention e P < 0.05 between Frzb À/À and littermates in DMM but not sham intervention with difference between means respectively À0.431 (95CI: À0.838; À0.024) for DMM and 0.254 (95%CI: À0.18; 0.687) for Sham (Sidak test). For the femur overall scoring was lower compared to tibia. DMM mice had significantly higher scores than sham-operated animals, but there was no interaction with the specific genotype. These data correspond with the OARSI position paper 11 indicating that the scoring of the femoral condyl is more challenging due to thinner cartilage, the definition of the tidemark and the convex shape of the condyles, hence leading to lower overall scores and larger error margins. For the Sfrp1 À/À mice as compared to littermates no interaction between genotype and intervention was seen at either the tibia or femur (Fig. 1) .
We measured the subchondral bone plate thickness of the medial tibial plateau of DMM-induced and sham-operated mice by histologic assessment at 8-weeks post surgery. The DMM model resulted in significantly greater subchondral bone changes compared to sham but was not different between Frzb À/À mice and littermates ((2-way ANOVA) P < 0.05 for intervention only). In contrast, the subchondral bone properties in Sfrp1 À/À mice were significantly different from littermates ((2-way ANOVA) P ¼ 0.04 for interaction between genotype and intervention) (Fig. 2) . Fig. 1(A)/2(A) ), as previously was also observed for human cartilage 12 . This staining was absent in Frzb À/À mice and appeared reduced in Sfrp1 À/À mice. We could not observe any Frzb in the subchondral bone of wild-type, Frzb À/À and Sfrp1 À/À mice.
Total beta-catenin staining was primarily located in the superficial layers of the articular cartilage ( Supplementary Fig. 1(B)/2(B) ). The staining suggested that more beta-catenin was present in Frzb À/À mice upon DMM surgery compared to sham-operated, whereas the opposite is true for Sfrp1 À/À mice. These data complement our findings that Frzb À/À and Sfrp1 À/À show different phenotypes upon DMM induction and may suggest that these findings are at least partly due to differences in canonical Wnt signaling. Due to technical limitations we could not achieve successful SFRP1 staining.
Discussion
Using the DMM model, we demonstrate that FRZB and SFRP1 differentially modulate joint homeostasis in two distinct compartments of the joint. These data highlight the relevance of Wnt signaling in joint surface and subchondral bone biology, and provide further evidence for a role of endogenous Wnt modulators as key players in these processes. Earlier in vivo data demonstrate that Frzb À/À mice are more prone to cartilage damage in different shortterm models of OA 4 . Transcriptome analysis of the bone-cartilage unit in joints of Frzb À/À mice further revealed that the Wnt pathway is tightly regulated with compensatory upregulation of other Wnt modulators in the absence of Frzb. Moreover, in vitro studies highlight the key function for Frzb in cartilage homeostasis 13 . Although Frzb À/À mice are reported with increased cortical bone thickness and density 4 , loss of Frzb did not lead to an increase of subchondral bone plate thickness compared to control in the DMM model. Targeted inactivation of another member of the SFRP family, Sfrp1, did not lead to increased cartilage degeneration upon DMM. However, we could observe thickening of the subchondral bone plate compared to control. The anabolic effect of loss of Sfrp1 on the subchondral bone is consistent with previous in vivo data. Genetic sham-operated (n ¼ 13) and Frzb À/À DMM (n ¼ 16). 2-way ANOVA P < 0.05 for genotype, intervention and interaction e P < 0.05 between Frzb À/À and littermates (Sidak test). Right:
deletion of Sfrp1 increases trabecular bone mass with a reduction in osteoblast and osteocyte apoptosis 14 . Sfrp1 may also inhibit osteoclastogenesis by binding of nuclear factor-kappaB ligand (RANKL), a ligand that is expressed by osteoblastic cells and promotes osteoclast differentiation through interaction with their cognate signaling receptor RANK 15 . Our data may imply that Sfrp1 plays mainly a role in the subchondral bone and not in the homeostasis of articular cartilage during OA. Previous studies by Zhu et al. already highlighted how Wnt signaling can affect joint homeostasis with both gain and loss of function for key signaling mediator beta-catenin resulting in OA-like phenotypes 7, 8 . Although the SFRP family has originally been identified as extracellular Wnt antagonists, it has become increasingly clear that they should be regarded as Wnt modulators (both in a positive and negative way) and that their interactome extends beyond Wnt ligands 5 .
Finally, the differential effects of loss of SFRP1 and FRZB on cartilage and subchondral bone in this model suggest that, at least in the initial phase of disease, cartilage and subchondral bone remodeling may be uncoupled or at least modulated by distinct Right: WT sham-operated (n ¼ 20), WT DMM (n ¼ 16), Sfrp1 À/À sham-operated (n ¼ 5) and Sfrp1 À/À DMM (n ¼ 11) (2-way ANOVA P < 0.05 for intervention and interaction).
